EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of potential quality markers of Zishen Yutai pill based on spectrum–effect relationship analysis

Sijia Wu, Qiuling Huang, Feiya Sheng, Lele Zhang, Liang Zou, Lele Yang, Jiliang Cao, Xiufei Pang, Na Ning, Peng Li

Frontiers in Pharmacology · 15.06.2023 · 14

DOI: 10.3389/fphar.2023.1211304 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 15.06.2023. Verfasst von Sijia Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The current quality evaluation of traditional Chinese medicine (TCM) is difficult to attribute to clinical efficacy due to the complexity of TCM. Zishen Yutai pill (ZYP), a well-known traditional Chinese patent medicine, has been widely used to prevent recurrent miscarriage and treat threatened abortion. However, the chemical components of ZYP are unknown, and there is no convincing quality control method applied on ZYP. Although ZYP has been found to promote endometrial receptivity and treat impending abortion, the substantial basis of the therapeutic effects is unclear. The aim of this study was to clarify the quality markers correlated with the potential medicinal activities and provide a theoretical foundation for scientific quality control and product quality improvement of ZYP.

Methods

The chemical constituents of ZYP were comprehensively analyzed by offline two-dimensional liquid chromatography-mass spectrometry (2DLC-LTQ-Orbitrap-MS). The efficacy of the 27 ZYP orthogonal groups was investigated using the HTR-8/SVneo oxidative damage model and migration model in vitro , as well as the endometrial receptivity disorder mouse model and premature ovarian failure mouse model in vivo . Based on the efficacy and mass spectral results, spectrum–effect relationship analysis was used to identify the chemical components with corresponding pharmacological activities.

Results

A total of 589 chemical components were found in ZYP, of which 139 were not identified in the literature. The potential quality markers for ZYP were successfully identified through orthogonal design and spectrum–effect relationship analysis. By combining mass spectrum data and pharmacological results of 27 orthogonal groups, 39 substances were identified as potential quality markers.

Conclusion

The approaches used in this study will provide a feasible strategy for the discovery of quality markers with bioactivity and further investigation into the quality evaluation of TCM.

Schlagwörter

Stichwörter der Autor:innen

Zishen Yutai pillin vitroin vivooffline two-dimensional liquid chromatography-mass spectrometryquality markersspectrum–effect relationshiptraditional Chinese medicine

Autor:innen und Institutionen

  • State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China.
  • Guangzhou Baiyunshan Zhongyi Pharmaceutical Co., Ltd., Guangzhou, Guangdong, China.
  • School of Basic Medical Sciences, Chengdu University, Chengdu, China.
  • School of Food and Biological Engineering, Chengdu University, Chengdu, China.
  • College of Pharmacy, Shenzhen Technology University, Shenzhen, China.

Zitieren

APA

Wu, S., Huang, Q., Sheng, F., Zhang, L., Zou, L., Yang, L., Cao, J., Pang, X., Ning, N., & Li, P. (2023). Identification of potential quality markers of Zishen Yutai pill based on spectrum–effect relationship analysis. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1211304

Vancouver

Wu S, Huang Q, Sheng F, Zhang L, Zou L, Yang L, et al. Identification of potential quality markers of Zishen Yutai pill based on spectrum–effect relationship analysis. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1211304

BibTeX
@article{Wu2023,
  author = {Wu, Sijia and Huang, Qiuling and Sheng, Feiya and Zhang, Lele and Zou, Liang and Yang, Lele and Cao, Jiliang and Pang, Xiufei and Ning, Na and Li, Peng},
  title = {Identification of potential quality markers of Zishen Yutai pill based on spectrum–effect relationship analysis},
  journal = {Frontiers in Pharmacology},
  year = {2023},
  volume = {14},
  doi = {10.3389/fphar.2023.1211304}
}
Kostenlos starten →